Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?

American Journal of Cardiology

Volumn 97, Issue 7, 2006, Pages 943-946

  Jungner, Ingmar ^a   Sniderman, Allan D ^c   Furberg, Curt ^d   Aastveit, Are H ^e   Holme, Ingar ^f   Walldius, Goran ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^f Center for Preventive Medicine   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARTICLE SIZE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TRIGLYCERIDES;

EID: 33645053280     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.10.062     Document Type: Article

References (21)

1. A.D. Sniderman, C.D. Furberg, A. Keech, J.E. Roeters van Lennep, J. Frohlich, I. Jungner, G. Walldius Apolipoproteins versus lipids as indices of coronary risk and as targets for statin therapy treatment Lancet 361 2003 777 780
2. C.J. Packard, J. Shepherd Lipoprotein heterogeneity and apolipoprotein B metabolism Arterioscler Thromb Vasc Biol 22 2002 274 282
3. H. Campos, E. Blijlevens, J.R. McNamara, J.M. Ordovas, B.M. Posner, P.W. Wilson, W.P. Castelli, E.J. Schaefer LDL particle size distribution. Results from the Framingham Offspring Study Arterioscler Thromb 12 1992 1410 1419
4. A.M. Wagner, D. Jorba, M. Rigla, E. Alonso, J. Ordonez-Llanos, A. Perez LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes Acta Diabetol 39 2002 215 220
5. A.D. Sniderman, B. Lamarche, J. Tilley, D.W. Seccombe, J. Frohlich Hypertriglyceridemic hyperapoB in type 2 diabetes Diabetes Care 25 2002 579 582
6. A.D. Sniderman, G.R. Dagenais, B. Cantin, J.P. Despres, B. Lamarche High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol Am J Cardiol 87 2001 792 793
7. A.D. Sniderman, A. St-Pierre, B. Cantin, G.R. Dagenais, J.-P. Depres, B. Lamarche Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk Am J Cardiol 91 2003 1173 1177
8. G. Walldius, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, E. Steiner High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study) a prospective study Lancet 358 2001 2026 2033
9. I. Jungner, S.M. Marcovina, G. Walldius, I. Holme, W. Kolar, E. Steiner Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials Clin Chem 44 1998 1641 1649
10. I. Jungner, G. Walldius, I. Holme, W. Kolar, E. Steiner Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 600 males and females J Lab Res 21 1992 247 255
11. G. Walldius, I. Jungner, W. Kolar, I. Holme, E. Steiner High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction: first report from the AMORIS (Apolipoprotein-related Mortality Risk Study) Blood Press 4 suppl 4 1992 35 42
12. S.M. Marcovina, J.J. Albers, H. Kennedy, J.V. Mei, L.O. Henderson, W.H. Hannon International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material Clin Chem 40 1994 586 592
13. S.M. Marcovina, J.J. Albers, L.O. Henderson, W.H. Hannon International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of International Reference Material Clin Chem 39 1993 773 781
14. P.J. Talmud, E. Hawe, G.J. Miller, S.E. Humphries Non-fasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men Arterioscler Thromb Vasc Biol 22 2002 1918 1923
15. J. Coresh, P.O. Kwiterovich, H.H. Smith, P.S. Bachorik Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women J Lipid Res 34 1993 1687 1697
16. D.S. Freedman, J. Otvos, E.J. Jeyarajah, I. Shalaurova, A.L. Cupples, H. Parise, R.B. D'Agostino, P.W.F. Wilson, E.J. Schaefer Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy the Framingham Study Clin Chem 50 2004 1189 1200
17. A.D. Sniderman, T. Scantlebury, K. Cianflone Hypertriglyceridemic hyperapoB the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus Ann Intern Med 135 2001 447 459
18. B. Lamarche, S. Moorjani, P.J. Lupien, B. Cantin, P.M. Bernard, G.R. Dagenais, J.P. Despres Apoprotein A-1 and B levels and the risk of ischemic heart disease during a 5-year follow-up of men in the Québec Cardiovascular Study Circulation 94 1996 273 278
19. G. Walldius, I. Jungner, A.H. Aastveit, I. Holme, C.D. Furberg, A.D. Sniderman The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between the plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk Clin Chem Lab Med 42 2004 1355 1363
20. B. Lamarche, J.P. Despres, S. Moorjani, B. Cantin, G.R. Dagenais, P.J. Lupien Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study) Am J Cardiol 75 1995 1189 1195
21. A.C. St-Pierre, B. Cantin, G.R. Dagenais, P. Mauriège, P.-M. Bernard, J.-P. Després, B. Larmache Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men. 13-year follow-up data from Quebec Cardiovascular Study Arterioscler Thromb Vasc Biol 25 2005 553 559